Company Filing History:
Years Active: 2002-2006
Title: Hak-Kim Chan: Innovator in Pharmaceutical Solutions
Introduction
Hak-Kim Chan is a notable inventor based in North Sydney, Australia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of liquid solutions for DNase, an important enzyme used in various medical applications. With a total of 2 patents, her work focuses on enhancing the stability and efficacy of pharmaceutical formulations.
Latest Patents
Hak-Kim Chan's latest patents revolve around the use of calcium ions and sugars to minimize thermal aggregation of DNase. The first patent addresses the stabilization of liquid solutions of DNase, which have a pH of less than neutral. This innovation is crucial as it allows for the effective pharmaceutical administration of DNase while preventing protein precipitation. The second patent further emphasizes the role of calcium ions in stabilizing these lower pH solutions, ensuring that the active pharmaceutical principle remains effective and safe for use.
Career Highlights
Hak-Kim Chan is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. Her work at Genentech has allowed her to collaborate with other talented professionals in the field, contributing to advancements in pharmaceutical science.
Collaborations
Some of her notable coworkers include Igor Gonda and Steven J. Shire. Their collaborative efforts have further enhanced the research and development of pharmaceutical solutions, showcasing the importance of teamwork in scientific innovation.
Conclusion
Hak-Kim Chan's contributions to the field of pharmaceuticals through her innovative patents highlight her role as a key inventor in the industry. Her work not only advances the understanding of DNase solutions but also paves the way for improved pharmaceutical applications.